Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access Program (SAP)

Name: Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access Program (SAP)
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

Drugs are authorized for sale in Canada once they have successfully gone through the drug review process, which includes the assessment of the safety, efficacy and quality of the drug. However, Health Canada's SAP allows practitioners to request access to drugs that are not available in Canada for the emergency treatment of patients with serious or life-threatening conditions who have exhausted other treatment options.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2021-12-29

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access Program (SAP) (English, HTML) HTML
Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access Program (SAP) (French, HTML) HTML

Related open data

Health Canada